Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia

被引：31

作者：

Gassner, Franz J. ^{[1
]}

Zaborsky, Nadja ^{[1
]}

Neureiter, Daniel ^{[2
]}

Huemer, Michael ^{[1
]}

Melchardt, Thomas ^{[1
]}

Egle, Alexander ^{[1
]}

Rebhandl, Stefan ^{[1
]}

Catakovic, Kemal ^{[1
]}

Hartmann, Tanja N. ^{[1
]}

Greil, Richard ^{[1
]}

Geisberger, Roland ^{[1
]}

机构：

[1] Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Ctr Oncol, Dept Internal Med Hematol Med Oncol Hemostaseolog, Salzburg, Austria

[2] Paracelsus Med Univ Salzburg, Dept Pathol, Salzburg, Austria

来源：

HAEMATOLOGICA | 2014年 / 99卷 / 05期

基金：

奥地利科学基金会;

关键词：

chronic lymphocytic leukemia; lenalidomide; T cell imhibitory receptors; CLL; DYSFUNCTION; MECHANISMS; DISEASE;

D O I：

10.3324/haematol.2013.098459

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E67 / E69

页数：3

共 15 条

[1] Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+T Cells Is Linked to Antigen Recognition and T Cell Differentiation [J].

Bengsch, Bertram ;

Seigel, Bianca ;

Ruhl, Marianne ;

Timm, Joerg ;

Kuntz, Martin ;

Blum, Hubert E. ;

Pircher, Hanspeter ;

Thimme, Robert .

PLOS PATHOGENS, 2010, 6 (06)

[2] The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia [J].

Brusa, Davide ;

Serra, Sara ;

Coscia, Marta ;

Rossi, Davide ;

D'Arena, Giovanni ;

Laurenti, Luca ;

Jaksic, Ozren ;

Fedele, Giorgio ;

Inghirami, Giorgio ;

Gaidano, Gianluca ;

Malavasi, Fabio ;

Deaglio, Silvia .

HAEMATOLOGICA, 2013, 98 (06) :953-963

[3] Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals [J].

Chidrawar, S. ;

Khan, N. ;

Wei, W. ;

McLarnon, A. ;

Smith, N. ;

Nayak, L. ;

Moss, P. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 155 (03) :423-432

[4] A Combination of Fludarabine/Rituximab with Escalating Doses of Lenalidomide in Previously Untreated Chronic Lymphocytic Leukemia (CLL): The REVLIRIT CLL5 AGMT Phase I/II Study, Clinical and Exploratory Analyses of Induction Results [J].

Egle, Alexander ;

Steurer, Michael ;

Gassner, Franz ;

Geisberger, Roland ;

Melchardt, Thomas ;

Weiss, Lukas ;

Fridrik, Michael A. ;

Thaler, Josef ;

Lang, Alois ;

Greil, Richard .

BLOOD, 2011, 118 (21) :135-136

[5] Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia [J].

Gassner, Franz Josef ;

Weiss, Lukas ;

Geisberger, Roland ;

Hofbauer, Josefina Pinon ;

Egle, Alexander ;

Hartmann, Tanja Nicole ;

Greil, Richard ;

Tinhofer, Inge .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (01) :75-85

[6] The immunodeficiency of chronic lymphocytic leukaemia [J].

Hamblin, A. D. ;

Hamblin, T. J. .

BRITISH MEDICAL BULLETIN, 2008, 87 (01) :49-62

[7] Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression [J].

Nunes, Claudia ;

Wong, Ryan ;

Mason, Malcolm ;

Fegan, Chris ;

Man, Stephen ;

Pepper, Chris .

CLINICAL CANCER RESEARCH, 2012, 18 (03) :678-687

[8] Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction [J].

Palmer, BE ;

Blyveis, N ;

Fontenot, AP ;

Wilson, CC .

JOURNAL OF IMMUNOLOGY, 2005, 175 (12) :8415-8423

[9] CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms [J].

Parry, RV ;

Chemnitz, JM ;

Frauwirth, KA ;

Lanfranco, AR ;

Braunstein, I ;

Kobayashi, SV ;

Linsley, PS ;

Thompson, CB ;

Riley, JL .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (21) :9543-9553

[10] Molecular and cellular mechanisms of CLL: novel therapeutic approaches [J].

Pleyer, Lisa ;

Egle, Alexander ;

Hartmann, Tanja Nicole ;

Greil, Richard .

NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (07) :405-418

← 1 2 →